Every asset begins with a nonproprietary, or generic, name. This name could potentially be the first strategic decision you make for the commercial life of your brand.
We guide the world’s top pharmaceutical companies in creating generic names, from initial development to final approval. Our resourceful team has thorough knowledge of drug classes and name stems to best classify – or create – the right category for a new generic name that meets both WHO and USAN regulations.
Through a collaborative and interactive process, we apply our proven methods to secure International Nonproprietary Names (INNs) that are appropriate for your asset and that pave the way for a strong brand to come.